We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





A Novel Capsule-Based Smell Test for Diagnosis of Neurological and Respiratory Diseases

By LabMedica International staff writers
Posted on 10 May 2021
Print article
Image: Photograph of the novel capsule-based smell test (Photo courtesy of Queen Mary University of London)
Image: Photograph of the novel capsule-based smell test (Photo courtesy of Queen Mary University of London)
To aid in diagnosing diseases where loss of the sense of smell is a symptom, such as in chronic neurological conditions like Parkinson's and Alzheimer's diseases and in acute respiratory infections such as that caused by COVID-19, a team of researchers at Queen Mary University of London (United Kingdom) developed a novel smell testing kit based on capsules of aromatic oils placed between two strips of single-sided tape.

This smelling test was made up of aromatic oil capsules that were prepared by a fabrication technique, which enabled full control over the capsule size, the shell thickness, and the volume of the encapsulated oil. The technique generated capsules by concentrically dripping oil/alginate droplets from a coaxial nozzle into an oppositely charged ionic liquid. After formation, liquid capsules were left to dry and form a solid crust surrounding the oil.

The prototype test used in the current study consisted of placing a standardized number of capsules between adhesive strips that users crushed and pulled apart to release the smell. In addition, a simple mathematical model was developed to predict the volume of encapsulated oil within the capsule in terms of the flow rate ratio and the nozzle size.

In this preliminary study, a small group of eight patients with Parkinson's disease were instructed to crush the capsules between their fingers and then peel back the tape strip to release the aroma contained within the capsules.

The participants reported that the smells from the tests were detectable and remarked on the relative ease of rupturing the capsules, particularly for those with tremors, compared to the standard scratch and sniff smell test available on the market.

First author Dr. Ahmed Ismail, a lecturer of fluid dynamics at Queen Mary University of London, said, "Most of the smell tests on the market depend on using paperboard items treated with a fragrant coating called scratch and sniff, in which you need to scratch a card to release the odor. The problem with this approach is that the amount of odor released depends on the extent to which the individual scratches, something that might affect the outcome of the test. Our capsule-based smell test does not have this problem because the amount of odor released is controlled by the amount of oil precisely encapsulated. The mass-production of our new test would also be cheaper than a scratch and sniff test.

Dr. Ismail said, "Our capsule-based smell test can assist in the rapid diagnostic of various diseases linked to the loss of smell. These include chronic neurological conditions such as Parkinson's and Alzheimer's disease, as well as COVID-19, which is known to affect the sense of smell. Being non-invasive and less stressful, the capsule-based smell test has benefits over the nose swab in diagnosing COVID-19. This is an advantage for testing children in particular, as they are typically horrified if they need to do a nose swab, and the test can be done in the comfort of their own home."

The capsule-based smell test was described in the April 28, 2021, online edition of the journal Royal Society Interface.

Related Links:
Queen Mary University of London

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.